| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Ghent University, Faculty of Veterinary Medicine, Department of Physiology, Biochemistry, and Biometrics, Salisburylaan 133, 9820 Merelbeke, Belgium
2 Institut National de Recherche Agronomique, Laboratoire de Pathologie Infectieuse et Immunologie, Centre de Tours-Nouzilly, 37380 Nouzilly, France
3 Bovine Functional Genomics Laboratory, USDA-ARS, Beltsville, MD 20705
Corresponding author: C. Burvenich; e-mail: christian.burvenich{at}UGent.be.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
Key Words: primiparous dairy cow • Escherichia coli • mastitis • inoculum size
Abbreviation key: BLC = blood leukocyte count, C5a = complement fragment 5a, LBP = LPS-binding protein, mCD14 = membrane-associated CD14, PIH = postinfusion hour, PMN = polymorphonuclear neutrophil, sCD14 = soluble CD14, TLR = Toll-like receptor, QMP = quarter milk production.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
Several of the proinflammatory cytokines that mediate the localized and systemic response to gram-negative mastitis, including IL-1ß, IL-6, IL-8, and TNF-
, are up-regulated by LPS (Shuster et al., 1993; Guha and Mackman, 2001). The up-regulation of these cytokines is mediated by the interaction of LPS with the accessory proteins, LPS-binding protein (LBP), and CD14 (Guha and Mackman, 2001). An acute phase protein binding with circulating LPS, LBP, facilitates the transfer of LPS to membrane-associated CD14 (mCD14), which is found on PMN and cells of the monocytic lineage (Wright et al., 1990). The mCD14 is a glycosyl phosphatidylinositol-anchored protein that lacks an intracellular cytoplasmic domain, rendering it incapable of signal transduction across the cell membrane. In cells lacking mCD14, such as epithelial and endothelial cells, activation is dependent on cellular recognition of LPS-LBP complexes bound to circulating soluble CD14 (sCD14), which is derived from the shedding of mCD14 (Tapping and Tobias, 1997) from CD14-bearing cells. Toll-like receptor (TLR)-4 has been identified in both cells of the monocytic lineage and non-mCD14-bearing cells as a LPS transmembrane receptor capable of activating cells (Chow et al., 1999; Faure et al., 2000). Recently, it was shown that LBP, in addition to transferring LPS to CD14, also forms an integral part of a trimolecular LPS-LBP-sCD14 complex. Monocytes can, therefore, detect the presence of LPS at concentrations as low as 10 pg/mL (Thomas et al., 2002). Transmembrane signaling and cell activation in cells lacking mCD14 are thought to be associated with TLR-4 through a cell surface assembly of a multiprotein recognition complex consisting of CD14, MD-2, and TLR-4 (Akashi et al., 2000). Activation and transmembrane signal transduction through the TLR-4 complex activates several NF-
B controlled genes such as IL-8 in endothelial cells (Aderem and Ulevitch, 2000).
A role for sCD14 and LBP in mediating bovine host responses to intramammary LPS or E. coli challenge has recently been demonstrated (Wang et al., 2002; Bannerman et al., 2003; Lee et al., 2003a, b). Following intramammary LPS infusion, sCD14 increases in milk (Bannerman et al., 2003; Lee et al., 2003a) paralleled by an increase in LBP (Bannerman et al., 2003). Moreover, sCD14 has been shown to sensitize the mammary gland to LPS (Wang et al., 2002) and to reduce the severity of experimental E. coli mastitis in mice (Lee et al., 2003c) and cows (Lee et al., 2003b). Interestingly, maximal levels of the chemoattractant IL-8 were observed before increases in either milk LBP or sCD14. This suggests that initial host cell activation can occur in the presence of basal levels of sCD14 and LBP (Bannerman et al., 2003). Furthermore, PMN influx, as determined by SCC, were similarly elevated before increases in sCD14 and LBP, indicating that heightened levels of these molecules were not required for immediate host innate immune responses (Bannerman et al., 2003).
Several physiological factors impact the clinical outcome of E. coli mastitis (Burvenich et al., 2003). Early lactating cows, infected with E. coli, are more severely affected than cows after peak lactation (Hill, 1981). This is mainly due to the impairment of early lactation leukocyte function, which begins a few weeks before parturition and only recovers several weeks postpartum (Kehrli et al., 1989; Sordillo and Babiuk, 1991a, b; Sordillo and Peel, 1992; Detilleux et al., 1995; Dosogne et al., 1999; Mehrzad et al., 2002). This pronounced immunosuppresion is not only related to parturition itself (Kimura et al., 1999), but it is influenced by several periparturient diseases (Kehrli and Goff, 1989) and has a consequence on many other diseases, such as retained placenta (Kimura et al., 2002). In addition to stage of lactation, parity was also reported to be an important physiological factor that influences severity of clinical mastitis (Gilbert et al., 1993; van Werven et al., 1997; Mehrzad et al., 2002; Vangroenweghe et al., 2004). Blood PMN function was higher in younger animals than in cows after their fourth parturition (Gilbert et al., 1993; van Werven et al., 1997). Moreover, PMN viability and oxidative burst activity have been found to be significantly different between primiparous cows and multiparous cows during the periparturient period (Mehrzad et al., 2002). In a nonrandomized intramammary challenge study using large numbers of E. coli, primiparous cows reacted as moderate responders based on their quarter milk production (QMP) in the noninfected quarter on d +2 postinfection. Based on clinical severity, all of the primiparous animals were scored as mild to moderate in their clinical response throughout the entire experimental challenge period (Vangroenweghe et al., 2004).
The purpose of the present study was to quantify several inflammatory mediators and cytokines and to evaluate the outcome of intramammary E. coli inoculation in primiparous cows under identical conditions as described previously (Vangroenweghe et al., 2004) with a fully randomized study design, using 2 high inoculum doses, with a 100-fold difference (1 x 104 and 1 x 106) in colony-forming units. This difference in inoculum dose was based on the amount of LPS produced related to the number of E. coli bacteria injected (Burvenich, 1983; Monfardini et al., 1999). The hypothesis of the present study is that the application of 2 different inoculum doses elicits differences of the innate immune response. An effect of 2 different inoculum doses in highly resistant primiparous cows has never been studied before, and it is important to have a better insight into the mechanism of innate immune response in these animals.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
For inclusion into the trial, treatment of clinical diseases was not allowed within 10 d before intramammary inoculation. Animals were free of major mastitis pathogens through 3 consecutive bacteriological examinations and with a quarter foremilk SCC <200,000 cells/mL. Primiparous cows accepted for the intramammary challenge were inoculated between 14 and 28 d postparturition.
Milking was performed daily at 0800 and 1800 h using a quarter milking machine (Packo & Fullwood, Zedelgem, Belgium). The QMP was measured at d –4, –1, 0 (postinfusion hour [PIH] 0 to 24), 1 (PIH 24 to 48), 2 (PIH 48 to 72), and 3 (PIH 72 to 96).
Inoculation Dose
The generation time of E. coli in mammary secretions can be as short as 20 min (Burvenich et al., 2003). Because we were interested in bacterial elimination rather than in bacterial growth in experimentally infected mammary glands, 2 high inoculum doses, 1 x 104 (Group A; n = 8) and 1 x 106 (Group B; n = 8) cfu, were used.
Intramammary Inoculation Procedure
Inoculation was performed as previously described (Vangroenweghe et al., 2004). Briefly, E. coli P4:O32 (Bramley, 1976) (H37, ß-glucuronidase +, haemolysin –), maintained in lyophilization medium at –20°C, was subcultured in brain-heart infusion broth (CM225; Oxoid, Nepean, ON, Canada) at 37°C during 3 consecutive d, subsequently washed 3x with pyrogen-free PBS, and resuspended in PBS. Just before inoculation, the suspension was diluted in pyrogen-free PBS to a final concentration of 1 x 104 cfu/mL (Group A) or 1 x 106 cfu/mL (Group B). On d 0, 30 min after morning milking (1.5 h after feeding), the cows were inoculated in the left front and rear quarters with a total volume of 10 mL, consisting of 1 mL of inoculum and 9 mL of pyrogen-free saline solution (NaCl 0.9%; Baxter N.V., Lessines, Belgium) per quarter.
Animals were randomly assigned to one of both treatment groups and challenged on 2 different trial d (8 cows per challenge day, 4 cows per treatment group).
Sampling Procedure
Blood and milk samples were collected at d –4, –1, 0, 1, 2, and 3 relative to the day of challenge. On the day of challenge, blood and milk samples were collected at PIH 3, 6, 9, 12, 15, 18, and 21.
Blood samples were drawn (10 mL) aseptically from the external jugular vein of each cow by venipuncture into evacuated tubes for preparation of plasma and serum. Foremilk was aseptically collected for diagnostic bacteriology, SCC, and preparation of skimmed milk. All samples were maintained on ice up to the time of processing.
Clinical Examination
Rectal temperature, heart rate, respiration rate, rumen motility, skin turgor, fecal appearance, appetite, general attitude, BCS (Edmondson et al., 1989), and aspects of the mammary gland (abnormal milk, swelling, teat relaxation, and milk leakage) (Massart-Leën et al., 1988) were recorded by a veterinarian each time blood and milk samples were collected.
Severity Determination
The severity of E. coli mastitis was determined based on QMP in the noninfected quarters at d 2 postinfusion. Animals with a QMP in the noninfected quarters at d +2 that was >50% compared with their QMP at d –1 in the same quarters were scored as moderate responders, whereas animals with a QMP at d +2 that was <50% were considered severe responders (Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997, 1999; Vangroenweghe et al., 2004). Clinical severity estimation was scored as described by Vangroenweghe et al. (2004). Briefly, clinical data (rectal temperature, skin turgor, reticulorumen motility, and general attitude) obtained from PIH 9 to 48 were scored as described in Table 1
, and based on their total score, primiparous cows were classified into mild, moderate, and severe responders.
|
Indicators of the Breakdown of the Blood-Milk Barrier
Milk samples for the determination of sodium, chlorine, and potassium concentrations (mM/L) were centrifuged at 1000 x g (30 min, 4°C). Fat was removed, and samples of skim milk were taken and immediately frozen at –80°C until analysis. After thawing, ion concentration was analyzed using an ion-selective electrode analyzer (Ilyte; Instrumentation Laboratories, Milan, Italy).
Blood Leukocyte Count and Differentiation
Blood leukocyte count (BLC) (log10/mL) was determined using an electronic particle counter (Coulter Counter Z2; Coulter Electronics Ltd., Luton, UK). Differential BLC was performed on blood smears. Briefly, 10 µL of mixed whole blood were added onto a microscope slide, and very thin smears were prepared. Following drying, smears were stained as described previously (Mehrzad et al., 2001). Differential counts of the blood smears were carried out according to Wilde (1964). Two hundred cells were counted on each smear, and the percentage of PMN (mature, band cells and myelocytes-metamyelocytes), monocytes, lymphocytes, and eosinophils was determined. Myelocytes-metamyelocytes were characterized by their round-oval to elongated-arciform nuclei with yellowish cytoplasm. Band cells had longer, circular formed nuclei with more condensed chromatin, situated near the periphery of the cell. Mature PMN had clearly defined nuclei with 3 to 6 lobes and typical neutral granules. Monocytes were round to irregular in shape containing greyish-blue cytoplasm, with foamy appearance in which fine red granules can be found. The nuclear substance has a fine reticulate structure with evenly distributed chromatin. Lymphocytes had compact nuclei, surrounded by cytoplasm varying from a narrow band to a wider, more irregular mass. Eosinophils had their specific eosinophilic granules in the cytoplasm and nuclei with 2 to 3 lobes.
Colony-Forming Units in the Inoculated Quarters
The number of E. coli (cfu/mL) after experimental inoculation was determined by appropriate 10-fold dilutions of each milk sample in PBS. Ten microliters of these dilutions were plated out on Columbia Sheep Blood agar (Biokar Diagnostics, Beauvois, France). All dilutions were performed in duplicate. Colonies were counted after a 24-h incubation at 37°C. The colony count was converted to cfu/mL based on the factor of dilution and finally expressed as log10/mL for statistical analysis.
ELISA for IL-8
Milk IL-8 levels were determined from undiluted whey samples assayed with a commercially available human IL-8 ELISA kit (R&D Systems, Inc., Minneapolis, MN). The antibody pairs used in this kit have been previously shown to cross-react with bovine IL-8 (Shuster et al., 1996, 1997). The optical density at 450 nm and a correction wavelength of 550 nm were measured on an automated microplate reader (Bio-Kinetics Reader; Bio-Tek Instruments, Winooski, VT). Values expressed in picograms per milliliter were extrapolated using linear regression from a standard curve of known amounts of human IL-8.
ELISA for Complement Fragment 5a
Using ELISA, the complement fragment 5a (C5a) was quantified as previously described (Rainard et al., 1998). Briefly, flat-bottomed microtiter plates (Immulon 1; Dynatech, Chantilly, VA) were coated with 100 µL of goat antimouse IgG (Jackson Immunoresearch Laboratories, West Grove, PA) diluted to 2 µg/mL in 0.1 M carbonate bicarbonate buffer (pH 9.6) for 1.5 h at 39°C. After each incubation, the plates were washed 5x with PBS supplemented with 0.1% (vol/vol) Tween 20. Unsaturated binding sites were blocked with a solution of 0.5% (wt/vol) gelatin. The sequence of incubation steps with 100-µL reagents diluted with PBS supplemented with 0.1% (vol/vol) Tween 20 plus 0.1% gelatin was as follows: 1) a 1/10,000 dilution of the antiC5a Mab 6G4 for 1 h; 2) 2-fold dilutions of purified C5adesArg for the calibration curve, or appropriate dilutions of the sample under test, diluted in PBS supplemented with 0.1% (vol/vol) Tween 20 plus 0.1% gelatin containing 1 mM EDTA for 1.5 h; 3) a 1/5000 dilution of rabbit antibovine C5a/C5 for 30 min; 4) a 1/10,000 dilution of goat antirabbit IgG (Jackson Immunoresearch Laboratories) for 30 min; 5) 52 mM 2,2'-azido-di-(3-ethylbenz-thiazoline-6-sulfonic acid) (ABTS; Sigma) in 0.1 M citrate buffer (pH 4.2) with 7.5 mM hydrogen peroxide (Sigma). The absorbance at 415 nm was read after about 30 min with an automated microplate reader (Bio-Kinetics Reader; Bio-Tek Instruments). Values expressed in nanograms per milliliter were extrapolated using linear regression from a standard curve of known amounts of C5adesArg (Rainard et al., 1998).
ELISA for sCD14
A sandwich ELISA was used to quantify sCD14 levels in milk as described by Bannerman et al. (2003). Briefly, flat-bottom 96-well plates were coated overnight with 5 µg/mL of mouse antibovine CD14 monoclonal antibody (CAM36A; VMRD, Inc., Pullman, WA) diluted in 0.05 M sodium carbonate-bicarbonate (Sigma) (pH 9.6) at 4°C. The plates were washed 4x with 0.05% Tween 20 diluted in 50 mM Trizma-buffered saline (Sigma) (pH 8.0) and subsequently blocked with 2% fish skin gelatin (Sigma Chemical Co.) for 1 h at room temperature. Plates were washed, and 100 µL of diluted whey samples (1:10) were added to each well in duplicate. Plates were incubated for 1 h at room temperature and subsequently washed as previously described. Mouse antibovine CD14 antibody (MM61A; VMRD, Inc.) was conjugated to horseradish peroxidase using a commercially available kit (EZ-Link Plus Activated Peroxidase Kit; Pierce Chemical Co., Rockford, IL) and was used as the detection antibody. This horseradish peroxidase-conjugated antibovine CD14 antibody was diluted 1:1000 in Trizma-buffered saline wash buffer containing 2% gelatin, and 100 µL of the resulting solution were added to each well. Plates were incubated for 1 h at room temperature and washed as previously described; 100 µL of 3,3',5,5'-tetramethylbenzidine substrate solution (Pierce Chemical Co.) were added to each well. The reaction was stopped by the addition of 100 µL of 2 M H2SO4, and the absorbance was read at 450 nm on a microplate reader (Multiskan PLUS; Labsystems, Helsinki, Finland). A background correction reading of 550 nm was subtracted from the 450-nm absorbance readings. Values expressed in micrograms per milliliter were extrapolated using linear regression from a standard curve of known amounts of recombinant bovine sCD14 (Wang et al., 2002).
ELISA for LBP
Milk and plasma LBP levels were determined with a commercially available LBP ELISA kit that cross-reacts with bovine LBP (Cell Sciences, Inc., Norwood, MA). Milk and plasma samples were diluted 1:400 and 1:1500, respectively, and assayed according to the manufacturer’s instructions. The optical density at 450 nm and a correction wavelength of 550 nm were measured on a microplate reader (Multiskan PLUS; Labsystems). The concentration of LBP was calculated by extrapolation using linear regression from a standard curve of known amounts of human LBP.
Statistical Analysis
To compare the 2 inoculum groups with respect to the various parameters analyzed in blood and milk, a mixed model was used, with cow as random effect and time, inoculum, and their interaction as categorical fixed effects. Furthermore, for the SCC, colony-forming units, rectal temperature, IL-8, C5a, sCD14, and LBP, the 2 inoculum doses were compared at PIH 6, 9, and 12 using Bonferroni’s multiple comparisons procedure with an overall type I error equal to 5%.
The significance between the number of animals in the different categories of the clinical score was tested using the Fisher Exact test.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
). The QMP decrease (68%) was slightly more pronounced in Group B, with a slightly more rapid recovery on d +1, but no significant differences between the 2 doses were found. On d +3, the recovery in the infected quarters was still incomplete and averaged 86 and 76% of the preinfection QMP in Groups A and B, respectively.
|
). Based on QMP at d +2, no severe responders were observed in the 2 groups. At d +3, relative to the day of infusion, QMP of these quarters was at 97 and 99% of the preinfection QMP in Group A and B, respectively.
Intramammary Challenge with E. coli Induces Both a Local and Systemic Inflammatory Response
After the intramammary E. coli inoculation in both infusion groups, rectal temperature rapidly increased and was significantly higher (P < 0.002) at PIH 6 and 9 in Group B compared with Group A. The fever peak appeared 3 h earlier and was highest in Group B, which received the 1 x 106 cfu inoculum (Figure 2a). As indicated by the significant interaction between time and inoculum (P < 0.0001), the kinetics of the rectal temperature curve significantly differed between the infusion groups. Heart rate and respiration rate followed identical kinetics as rectal temperature (results not shown).
|
Local clinical signs at the level of the infected mammary glands appeared early during inflammation. In Group B, the first changes in milk appearance (color, flakes, etc.) occurred at PIH 9, with a maximum around PIH 15. Swelling of the infected quarters occurred at PIH 6, with a maximum on PIH 9, at the time when PMN influx in the glands became apparent through increases in SCC. Pronounced swelling disappeared gradually, and it was already at a low level (6 quarters with moderate swelling) at PIH 72. In the group receiving the low inoculum dose, changes in milk appearance and quarter swelling were equal to Group B, but the onset was about 3 h later. Teat relaxation, milk leakage, and diarrhea only appeared in a small number of animals in both infusion groups. The BCS decreased slightly from 3.5 to 2.5 from arrival at the dairy facility until the end of the intramammary E. coli challenge.
Intramammary E. coli Challenge Induces Mainly Mild and Moderate Responses in Primiparous Cows Based on a Clinical Severity Scoring
Based on the clinical severity scoring by Vangroenweghe et al. (2004), clinical changes appeared earlier in Group B compared with Group A. At PIH 9, 6 animals in Group B (n = 8) had a moderate clinical score; however, in Group A (n = 8), only 1 animal reacted moderately, whereas the others still exhibited a mild response (P = 0.041). By PIH 12, only 4 animals in Group B (n = 8) reacted moderately, whereas in Group A (n = 8), 6 animals showed a moderate response (P = 0.61) (Table 2). The clinical score normalized from PIH 15 onward, with only one animal in each group reacting moderately at PIH 15 and none at PIH 18. No severe responses were observed in either of the infusion groups at any time point between PIH 9 and 48.
|
).
The SCC rapidly increased following intramammary E. coli infection and was significantly (P < 0.0001) higher at PIH 6 in the high dose infusion group compared with the group receiving the low dose. At PIH 9, both infusion groups reached a plateau level of 106.57 cells/mL (Figure 3f). Peak SCC levels were reached at PIH 15 and 18 in Groups B and A, respectively. The SCC kinetics significantly differed (P = 0.0005) between the inoculum groups, especially because of the earlier cellular influx (PIH 6) in the infected quarters in Group B. At PIH 72, SCC did not yet attain preinfection SCC levels.
|
).
Intramammary E. coli Challenge Induces the Appearance of Immature PMN into the Blood Circulation
Following intramammary challenge, marked changes in differential BLC appeared, resulting in an increased number of early (myelocytes-metamyelocytes) and late (band cells) immature PMN in the blood circulation. Band cells increased from PIH 3 to peak at PIH 12 (Group B; 29.1 ± 6.4%) and PIH 15 (Group A; 27.2 ± 2.4%). A second peak was observed at PIH 21 (32.3 ± 2.8 and 31.6 ± 4.0% in Groups A and B, respectively), after which the percentage of band cells decreased to normal levels by PIH 216 (Figure 3i). Early immature cells (myelocytes-metamyelocytes) appeared more frequently in the circulation from PIH 12 (Group B) and PIH 15 (Group A) onward, with peak values at PIH 18 (Group A; 24.1 ± 2.5%) and PIH 21 (Group B; 18.8 ± 1.1%). Myelocytes-metamyelocytes gradually decreased in the following 96 h to reach normal levels at PIH 144 to 216 (Figure 3h).
Mature PMN migrated from the circulation into the infected quarters, which resulted in a decreased percentage from PIH 9 onward in both groups, with nadir at PIH 15 (1.0 ± 0.6 and 3.5 ± 2.0% in Groups A and B, respectively). The percentage of circulating mature PMN gradually recovered and reached preinfection values by PIH 144 (Figure 3j).
Intramammary E. coli Challenge Induces Disruption of the Blood-Milk Barrier and Stimulates IL-8 and C5a Production in the Mammary Gland
Lactose, sodium, potassium, and chloride are good indicators to assess the damage of the blood-milk barrier caused by the present IMI. Lactose decreased significantly in Group B from PIH 6 onward, to nadir at PIH 12 in both groups. In Group A, the disruption of the blood-milk barrier appears 3 h later, with a decrease in lactose content at PIH 9 (Figure 2c). Similarly, sodium and chloride concentrations in Group B increased from PIH 6 to peak a first time at PIH 9. Following a slight decrease at PIH 15, a second peak was reached at PIH 18. In Group A, infused with 1 x 104 cfu per quarter, the onset of increased concentrations of sodium and chloride appeared at PIH 9, with maximal concentrations at PIH 18 (Figure 2, d and f). In contrast with the observed changes in sodium and chloride concentrations, potassium kinetics did not significantly differ between both infusion groups. Nadir was reached at PIH 12, followed by a slow restoration of initial potassium levels by PIH 48 (Figure 2e).
Before challenge, IL-8 was hardly detectable (2.19 ± 0.93 and 1.89 ± 0.84 pg/mL in Groups A and B, respectively) in the quarters that were to be infused with E. coli. The IL-8 kinetics of the 2 infusion groups differed significantly from each other. In Group B, a significant increase in IL-8 appeared as early as PIH 6 and reached a peak of 305 ± 36 pg/mL at PIH 12 (Figure 3a). At PIH 6 and 9, the concentration of IL-8 in the inflamed quarters was significantly higher (P < 0.05) in Group B, which received the 1 x 106 cfu inoculum dose. Following infusion of 1 x 104 cfu (Group A), significant increases in IL-8 occurred at PIH 9 and reached peak levels of 240 ± 40 pg/mL at PIH 12. Elevated levels of IL-8 persisted until PIH 24 in both groups, after which the levels returned to baseline.
The complement component C5a had similar kinetics in both groups. The initial increase in C5a following intramammary challenge appeared at PIH 6 (±1.5 ng/mL), and it rapidly increased to 37.1 ± 16.0 ng/mL and 30.6 ± 12.4 ng/mL at PIH 12 for Groups A and B, respectively. Elevated levels of C5a persisted until PIH 24 in both groups, after which the levels returned to baseline (Figure 3b).
Intramammary E. coli Challenge Increases Milk sCD14 Levels
To determine whether E. coli could alter mammary gland levels of sCD14, a sandwich ELISA was used to quantitate milk sCD14 (Figure 3c). Before challenge, sCD14 in mammary quarters (7.7 ± 2.7 and 10.4 ± 3.1 µg/mL for Groups A and B, respectively) was in the range previously described (Lee et al., 2003a) for early lactating noninfected glands (5.46 to 6.90 µg/mL). At PIH 6, a significant increase in milk sCD14 was observed in Group B, whereas in Group A, the increase in milk sCD14 only appeared at PIH 9. Concentrations of sCD14 were significantly (P < 0.0001) different between the 2 groups at PIH 12. Milk sCD14 peaked at PIH 15 in both groups, although the level of sCD14 was significantly higher (P = 0.0323) (205 ± 44 µg/mL) in Group B compared with Group A (151 ± 54 µg/mL) (Figure 3c).
Increased Levels of LBP in Milk Following Intramammary Challenge with E. coli
It has been shown previously (Bannerman et al., 2003) that elevated levels of sCD14 are associated with similar increases in milk LBP, thereby providing an environment for optimal host recognition of LPS, originating from infused E. coli bacteria. Plasma LBP was also assayed, as it is known that hepatic synthesis of this protein increases during the acute phase response, mainly because of hepatic cell stimulation by IL-1ß and IL-6 (Tobias et al., 1999). Under basal conditions, LBP was detected in bovine blood at concentrations of 29.8 ± 7.5 and 41.9 ± 5.4 µg/mL for Groups A and B, respectively; whereas the concentration of LBP in milk was lower with 8.5 ± 5.1 and 14.5 ± 11.5 µg/mL for Groups A and B, respectively. At PIH 9, plasma LBP in Group B increased, and this increase persisted throughout the entire study period (Figure 3d). Plasma LBP levels reached maximal levels of 70.1 ± 1.5 and 68.8 ± 1.1 µg/mL at PIH 18, after which they slightly declined to reach a plateau until the end of the study. In quarters inoculated with E. coli, significant elevation of milk LBP was observed as early as PIH 9, resulting in a first peak at PIH 15 (44.4 ± 10.6 and 40.4 ± 8.7 µg/mL in Groups A and B, respectively). Milk LPB was significantly (P = 0.0431) higher in Group B at PIH 12. A second peak (61.6 ± 12.3 and 61.2 ± 12.0 µg/mL in Groups A and B, respectively) was reached at PIH 24, after which milk LBP levels remained high until the end of the study (Figure 3e). Peak levels of milk LBP were observed 6 h later than the maximal elevation of plasma LBP levels.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
The number of circulating PMN, a marker to predict the clinical outcome of the disease, was similar to the levels previously observed in moderate responders (Vandeputte-Van Messom et al., 1993; Vangroenweghe et al., 2004). Primiparous cows in this study could, therefore, be expected to react with a moderate clinical response. Following intramammary E. coli challenge, a rapid decrease of circulating PMN was observed, which coincided with the influx of PMN into the infected quarters and started around PIH 6 to 9. Remarkably, no significant difference in BLC kinetics could be observed between the infusion groups, whereas, for SCC, a significantly earlier influx was observed in the high dose inoculum group.
The onset of local clinical signs of mastitis, characterized by quarter swelling, coincided with the influx of PMN to the infected quarters. The SCC increased rapidly in both groups, which is in accordance with earlier observations, where moderate responders had a rapidly occurring leukocytosis in the infected glands (Vandeputte-Van Messom et al., 1993). However, in the present study, distinct differences in the onset of PMN influx into the infected glands could be observed. The extraction of mature PMN from the blood to the infected glands is known to result in early and late immature PMN recruitment from the bone marrow to restore the number of circulating PMN. Recently, IL-8 has been shown to be responsible for rapid granulocytosis with the release of PMN from the bone marrow (Terashima et al., 1998). In the present study, IL-8 was released from PIH 6 to 9, which coincided with the appearance of significantly increased numbers of band cells in the blood circulation. However, the recruitment of PMN was of short duration, compared with Heyneman et al. (1990), who observed immature forms in circulation for at least 3 d in moderate responders and for almost 10 d in severe responders.
The rapid influx of PMN into the infected glands was associated with rapid elimination of bacteria from the quarters. In contrast to an earlier study with the same inoculum dose in multiparous animals (Vandeputte-Van Messom et al., 1993), peak bacterial numbers were already reached around PIH 3 to 6, which was in accordance with a previous study in primiparous cows (Vangroenweghe et al., 2004). Contrary to the induction of E. coli mastitis with low inoculum doses, where elimination is preceeded by excessive bacterial growth (Shuster et al., 1996, 1997; Riollet et al., 2000; Scaletti et al., 2003), in this study, peak numbers were reached within 6 h postinfusion and followed by a subsequent bacterial elimination.
Several indicators (lactose, sodium, chloride, and potassium) for the disintegration of the blood-milk barrier were determined in this study. The changes appeared significantly earlier (approximately 3 h) in Group B, receiving the 1 x 106-cfu inoculum dose, although peak levels were almost identical for both groups, which coincides with all other data, indicating that the animals reacted with a mild to moderate response and little variation in clinical response was present in this study.
Complement component C5a and its derivative C5adesArg play a potential role in the inflammatory response accompanying mastitis (Rainard et al., 1998). The level of C5a/C5adesArg on the day of challenge was within the range previously described by Rainard et al. (1998), taking into account that the average SCC immediately before intramammary infusion was a little higher (approximately 90,000 vs. 25,000 cells/mL). In the present study, increased levels of C5a/C5adesArg could be observed from PIH 3 onward, which is in accordance with an earlier study (Rainard et al., 1998), although in that study the induction of inflammatory symptoms was performed with E. coli endotoxin and not with live bacteria. The assessment of C5adesArg concentrations in milk following infusion of E. coli endotoxin or live bacteria showed that biologically significant amounts of C5a/C5adesArg are present in mastitic milk. The bulk of complement-derived components in mastitic milk are likely to have their origin in blood plasma, exudating through the damaged blood-milk barrier following inflammation of the mammary gland (Rainard et al., 1998). However, milk concentrations of C5a/C5adesArg are probably not a reliable indicator of exudation, as C5a/C5adesArg is rapidly taken up by several cell types present in inflamed milk, in particular PMN (Rainard et al., 1998). Major clearance mechanism of this inflammatory mediator is believed to rely on the binding of C5a/C5adesArg to cell surface receptors. As milk from inflamed quarters contained high concentrations of cells, mainly PMN, it can be put forward that the concentrations of C5a/C5adesArg measured in milk were underestimates of the total amounts of C5a/C5adesArg originally generated. Complement fragment 5a generated in milk could well contribute to the activation of the recruited phagocytic cells, with the consequence of improving their bactericidal activity (Rainard, 2003).
Interleukin-8 is considered to play an important role in PMN recruitment to the inflamed quarters (Baggniolini and Clark-Lewis, 1992; Barber and Yang, 1998). In contrast to Shuster et al. (1997), who suggested the importance of C5a is greater than IL-8 during the early inflammatory response mainly because of earlier peak maxima, in the present study, peak levels of IL-8 appeared 6 h earlier than C5a. The increase of IL-8 chemotactic activity appears coincident with the increment in SCC at the level of the infected quarters. An increase in C5a also appeared as early as PIH 3 to 6, but its peak maximum was only reached at PIH 18. The induction of IL-8 production and release is known to be independent of the presence of IL-1ß and TNF- (Persson-Waller et al., 2003).
Detectable increases in milk LBP were observed after initial increases in blood LBP, and maximal levels of LBP in milk were observed at PIH 24, some 6 h after the peak levels of plasma LBP. In accordance with Bannerman et al. (2003), the increases in milk LBP paralleled increments in sCD14 levels. From a host perspective, the simultaneous increase in both LBP and sCD14 levels would be expected to be advantageous as both molecules act in concert to facilitate activation of host defense mechanisms by presenting LPS, released during bacterial growth and death, to the transmembrane LPS receptor, TLR-4 (Bannerman and Goldblum, 2003). Although the increase in sCD14 was earlier and significantly higher in Group B, PMN influx as determined by SCC in the infected quarters was similarly elevated before pronounced increment of sCD14. It was proposed that heightened levels of these molecules are not required for immediate host innate immune responses (Bannerman et al., 2003). However, peak levels of SCC were not observed until PIH 15 to 18, at a time where levels of both sCD14 and LBP in milk were elevated. Whether increments in sCD14 and LBP are necessary for maximal recruitment of PMN to the in-flamed mammary glands remains unknown.
From this study, it appears that the inflammatory response in primiparous cows from Group B has an earlier onset compared with Group A. One possible explanation for this observation could be the 100-fold difference in the number of E. coli infused into the mammary glands because the amount of LPS produced is related to the number of E. coli bacteria (Burvenich, 1983; Monfardini et al., 1999). Because the bacterial cultures were washed 3x in pyrogen-free PBS before further dilutions were made, a direct effect of LPS present in the inoculum can be excluded. Known as a potent inducer of inflammatory cytokines (Shuster et al., 1993), LPS can be produced quite rapidly during bacterial growth following intramammary infusion. The infused bacteria rapidly activated the complement system through the alternative pathway, resulting in an early abundant production of C5a. These effects resulted in a rapid attraction of PMN from the blood into the mammary gland, with a subsequent pronounced increase of SCC in the infected glands.
The novelty of the present study is the fact that primiparous cows, recently shown to react as mild to moderate responders (Vangroenweghe et al., 2004), are responding faster following a 100-fold increase in the inoculum dose. This quicker response is related to an earlier activation of innate host immunity.
Following E. coli mastitis, treatment with antibiotics at PIH 10 did not alter local and systemic symptoms despite a 100-fold decrease in colony-forming units (Monfardini et al., 1999). From the present study, it is evident that at the set time point, antibiotic treatment is unable to alter the production or release of various inflammatory mediators. Therefore, it can be suggested that early inflammatory events (first 3 h) could play a major role in the further regulation of the inflammatory response to combat the invading pathogens.
|
CONCLUSIONS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
|
ACKNOWLEDGEMENTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
Received for publication February 9, 2004. Accepted for publication June 21, 2004.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONCONCLUSIONSACKNOWLEDGEMENTSREFERENCES |
|---|
B through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058–11063. in the pathogenesis of experimentally induced coliform mastitis in periparturient cows. J. Dairy Res. 67:503–514.[Medline]
This article has been cited by other articles:
|
|
 |
|
  D. D. Bannerman Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows J Anim Sci, April 1, 2009; 87(13_suppl): 10 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Bannerman, A. C. W. Kauf, M. J. Paape, H. R. Springer, and J. P. Goff Comparison of Holstein and Jersey Innate Immune Responses to Escherichia coli Intramammary Infection J Dairy Sci, June 1, 2008; 91(6): 2225 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mehrzad, D. Janssen, L. Duchateau, and C. Burvenich Increase in Escherichia coli Inoculum Dose Accelerates CD8+ T-Cell Trafficking in the Primiparous Bovine Mammary Gland J Dairy Sci, January 1, 2008; 91(1): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. W. Kauf, R. F. Rosenbusch, M. J. Paape, and D. D. Bannerman Innate Immune Response to Intramammary Mycoplasma bovis Infection J Dairy Sci, July 1, 2007; 90(7): 3336 - 3348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Burvenich, D. D. Bannerman, J. D. Lippolis, L. Peelman, B. J. Nonnecke, M. E. Kehrli Jr., and M. J. Paape Cumulative Physiological Events Influence the Inflammatory Response of the Bovine Udder to Escherichia coli Infections During the Transition Period J Dairy Sci, June 1, 2007; 90(13_suppl): E39 - E54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Detilleux, F. Vangroenweghe, and C. Burvenich Mathematical Model of the Acute Inflammatory Response to Escherichia coli in Intramammary Challenge. J Dairy Sci, September 1, 2006; 89(9): 3455 - 3465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Bannerman, M. J. Paape, R. L. Baldwin VI, C. P. Rice, K. Bialek, and A. V. Capuco Effect of mastitis on milk perchlorate concentrations in dairy cows. J Dairy Sci, August 1, 2006; 89(8): 3011 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vangroenweghe, L. Duchateau, P. Boutet, P. Lekeux, P. Rainard, M. J. Paape, and C. Burvenich Effect of Carprofen Treatment Following Experimentally Induced Escherichia coli Mastitis in Primiparous Cows J Dairy Sci, July 1, 2005; 88(7): 2361 - 2376. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
